SALVALAIO, MARIKA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.110
EU - Europa 201
AS - Asia 93
Totale 1.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.109
IT - Italia 88
CN - Cina 77
SE - Svezia 40
FI - Finlandia 33
GB - Regno Unito 13
DE - Germania 11
UA - Ucraina 10
IN - India 9
KR - Corea 4
IE - Irlanda 2
SG - Singapore 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
NL - Olanda 1
PA - Panama 1
Totale 1.404
Salva come PNG Salva come JPEG
Città #
Fairfield 144
Chandler 127
Ann Arbor 120
Houston 115
Woodbridge 90
Ashburn 89
Cambridge 68
Wilmington 50
Seattle 47
Padova 34
Jacksonville 31
Helsinki 26
Beijing 20
Princeton 17
Medford 15
Boardman 14
Des Moines 14
Nanjing 12
New York 12
San Diego 11
Milan 8
Cagliari 6
Falls Church 5
Guangzhou 5
Jinan 5
Nanchang 5
Roxbury 5
Catania 4
Venice 4
Auburn Hills 3
Los Angeles 3
Parma 3
Pune 3
Shenyang 3
Tappahannock 3
Aprilia 2
Bengaluru 2
Bologna 2
Changsha 2
Dublin 2
Jung-gu 2
London 2
Munich 2
Ogden 2
Prato 2
Rome 2
Suwon 2
Vicenza 2
Washington 2
Amsterdam 1
Andover 1
Anguillara Veneta 1
Bassano Del Grappa 1
Boquete 1
Casalecchio di Reno 1
Chicago 1
Chongqing 1
Dongguan 1
Gunzenhausen 1
Harrow 1
Hebei 1
Hefei 1
Huzhou 1
Jinhua 1
Kameari 1
Kharkiv 1
Kunming 1
Lanzhou 1
Messina 1
Newark 1
Ningbo 1
Phoenix 1
Sant'elena 1
Sassuolo 1
Selvazzano Dentro 1
Shanghai 1
Singapore 1
Treviso 1
Turin 1
Xian 1
Yellow Springs 1
Totale 1.181
Salva come PNG Salva come JPEG
Nome #
Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II 175
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 148
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 130
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 129
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 99
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII). 87
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. 85
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 75
Loss of lysosomal iduronate sulfatase function perturbs FGF signaling and the expression of downstream key osteogenic factors. 66
Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates 65
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 62
Valutazione del profilo di espressione genica cerebrale nel modello murino per la mucopolisaccaridosi di tipo II (sindrome di Hunter) effettuata mediante tecnologia RNA-Seq 60
The zebrafish model as a novel tool to uncover the complex bone pathogenesis of type I Gaucher disease 57
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 54
In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target 54
Browning Effects of a Chronic Pterostilbene Supplementation in Mice Fed a High-Fat Diet 51
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 15
Corrigendum: FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII) [Human Molecular Genetics, 27, 13, (2018) (2262-2275)] DOI: 10.1093/hmg/ddy131 14
Totale 1.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.243
article - articoli 4.349
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201966 0 0 0 0 0 0 0 0 0 0 36 30
2019/2020222 30 8 1 16 18 13 25 27 23 39 14 8
2020/2021255 9 10 25 9 20 10 22 24 34 53 26 13
2021/2022247 11 25 30 14 28 16 13 25 15 7 16 47
2022/2023258 32 29 6 30 46 34 0 19 43 9 8 2
2023/2024171 12 21 24 20 14 31 15 17 6 11 0 0
Totale 1.426